Pelvic Floor Disorders Network (UG1 Clinical Trial Required) | RFA HD 22 021

Opportunity Information: Apply for RFA HD 22 021

The Pelvic Floor Disorders Network (UG1 Clinical Trial Required) opportunity (RFA-HD-22-021) is a National Institutes of Health (NIH) cooperative agreement run through the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD). It is meant for institutions that want to join an established, multicenter clinical research program focused on pelvic floor disorders in adult women. In practical terms, the program supports coordinated, network-based studies that examine both clinical outcomes and broader health impacts of these conditions, with the expectation that funded sites will actively participate in a collaborative structure rather than operate as completely independent research projects. Because this is a UG1 mechanism and explicitly marked as “Clinical Trial Required,” applicants should expect that proposing and conducting clinical trials is a central part of the work, and that awardees will follow NICHD network protocols, data standards, and coordination requirements typical of NIH cooperative agreements.

The funding instrument is a cooperative agreement, which generally means NIH/NICHD will have substantial involvement in the funded activities compared with a standard grant. Awards fall under the Health, Income Security and Social Services activity category, and the listed CFDA numbers are 93.313 and 93.865. The opportunity was created on October 13, 2021, and the original closing date was December 6, 2021. The posted award ceiling is $170,000, indicating an upper limit referenced in the announcement materials (applicants would normally confirm how that ceiling applies in the full FOA, such as whether it is direct costs, total costs, per year, or another structure). The number of expected awards is not specified in the provided source data.

Eligibility is broad across government, academic, nonprofit, and private-sector entities. Eligible applicants include state, county, city/township, and special district governments; independent school districts; public and state-controlled institutions of higher education; private institutions of higher education; federally recognized Native American tribal governments; tribal organizations other than federally recognized governments; public housing authorities/Indian housing authorities; nonprofits with and without 501(c)(3) status (other than institutions of higher education); for-profit organizations other than small businesses; and small businesses. The FOA also explicitly highlights additional eligible applicant types such as Alaska Native and Native Hawaiian Serving Institutions, Asian American Native American Pacific Islander Serving Institutions (AANAPISIs), Hispanic-serving Institutions, Historically Black Colleges and Universities (HBCUs), Tribally Controlled Colleges and Universities (TCCUs), faith-based or community-based organizations, eligible federal agencies, regional organizations, and U.S. territories or possessions.

At the same time, the opportunity places firm restrictions on foreign participation. Non-domestic (non-U.S.) entities (foreign institutions) are not eligible to apply, non-domestic components of U.S. organizations are not eligible, and foreign components as defined by the NIH Grants Policy Statement are not allowed. In other words, the work and organizational participation must remain domestic under NIH definitions, and applicants should plan staffing, study sites, data collection, and subcontracting accordingly to avoid disallowed foreign components.

Overall, this FOA is best understood as an invitation to become part of a standing NICHD clinical research network dedicated to improving evidence and care strategies for pelvic floor disorders in adult women through coordinated multicenter clinical studies, with NIH playing an active partnership role typical of the UG1 cooperative agreement model.

• The National Institutes of Health in the health, income security and social services sector is offering a public funding opportunity titled "Pelvic Floor Disorders Network (UG1 Clinical Trial Required)" and is now available to receive applicants.
• Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.313, 93.865.
• This funding opportunity was created on 2021-10-13.
• Applicants must submit their applications by 2021-12-06. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
• Each selected applicant is eligible to receive up to $170,000.00 in funding.
• Eligible applicants include: State governments, County governments, City or township governments, Special district governments, Independent school districts, Public and State controlled institutions of higher education, Native American tribal governments (Federally recognized), Public housing authorities/Indian housing authorities, Native American tribal organizations (other than Federally recognized tribal governments), Nonprofits having a 501 (c) (3) status with the IRS, other than institutions of higher education, Nonprofits that do not have a 501 (c) (3) status with the IRS, other than institutions of higher education, Private institutions of higher education, For-profit organizations other than small businesses, Small businesses, Others.

Apply for RFA HD 22 021

[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal: